english.prescrire.org > Prescrire International > N°176 - November 2016

n°176

November 2016

Issue Contents
Editorial

Free  Pesticides: their true costs are wildly underestimated

p.256
An illuminating approach worth applying to healthcare

New Products


Panobinostat (Farydak°)

p.257-259
Multiple myeloma: too toxic!

INN Common stem: -rubicin

p.259

Idarucizumab (Praxbind°)

p.260-263
Don't rely too heavily on this dabigatran antidote

Lenalidomide (Revlimid°) in untreated multiple myeloma

p.263-264
A few extra months of life but slightly more toxic

Adverse Effects


Human papillomavirus vaccines and Guillain-Barré syndrome: managing uncertainties

p.265-270

Autoimmune diseases and vaccines

p.266-267

Guillain-Barré syndrome, in brief

p.268

HPV vaccines: too soon to detect an impact on mortality

p.268

Cervical cancer: screen regularly; maybe vaccinate

p.269
Editors' opinion

Bevacizumab: vocal cord necrosis

p.270
Angiogenesis inhibitors in cancer affect healthy tissues

Opioids: adrenal insufficiency

p.271
All opioids are implicated

Aripiprazole: impulse control disorders

p.271
Pathological gambling

Aflibercept: osteonecrosis of the jaw

p.271
Watch out for high-risk situations

Reviews


Chronic obstructive pulmonary disease

p.272-277
Useful medications for patients with recurrent symptoms

Drugs for chronic obstructive pulmonary disease

p.275
Prescrire's advice

Outlook


Free  More on domperidone and sudden cardiac death

p.278-279
French opinion leaders and regulators in the hot seat

Masthead


Free  Masthead

p.254

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe